title: Company is blamed for early halt of trial into obesity treatment.
authors.affiliation: London.
authors.forename: Jacqui
authors.initials: J
authors.lastname: Wise
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects*; D016642:Bupropion / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D057239:Early Termination of Clinical Trials; D005260:Female; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000009:adverse effects*; D009765:Obesity / Q000188:drug therapy*
chemical_list: D019440:Anti-Obesity Agents; D016642:Bupropion; D009271:Naltrexone